Rob Hartman, PhD

Rob Hartman, PhD, has more than 14 years of health care and commercialization experience. He is currently vice president of Translational Science at UPMC Enterprises, where he guides investment strategy and diligence with a leadership role in medical devices, supports strategy for portfolio companies, and serves as a connector of teams and opportunities spanning life sciences and digital health technology. He has focused on AI-enabled drug discovery and worked on multiple data science driven discovery partnerships and portfolio opportunities.

Before moving to Translational Sciences, Dr. Hartman led the Pittsburgh Health Data Alliance, a program that enables UPMC to support and commercialize potentially disruptive innovation in health care with multi-million-dollar annual investments in health-related, data-intensive, local, academic research.

Prior to working with UPMC, he was an innovation and commercialization consultant within the University of Pittsburgh where he received his bachelor’s, master’s, and doctorate degrees in bioengineering.